Title: Trevena, Inc.
Description: Trevena, Inc. is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G-protein coupled receptor (GPCR) targeted medicines.
Keywords:
Trevena,
Biased Ligands,
pharmaceutical,
Ligand,
GPCR,
TRV027,
TRV130,
G-protein coupled receptor,
Maxine Gowen,
signal specificity,
Robert Lefkowitz,
Duke University,
angiotensin,
beta-arrestins